Gnawkz: Exquisite exposition from a shrewd operator of doing what sadly few have done (resulting in large loss of precious capital has impacted the shares in 2014) that removes lots of the time expiration issues since L has been reset; Direct results from MD Anderson appearing to be in conformity vs anecdotal updates; Direct expanding to UCLA; preparing Germany/UK ramping for eventual commercial rollout etc.
From the companies perspective HIGHEST PRIORITY is to deploy capital to get us over the BUSINESS hump vs the administration issues (CFO; IR etc) which will take place. Posters that perpetually harp on the latter, FAIL to understand: developing the business is first priority; employees are a close second; and last are shareholders! LP is qualified as a CFO but when she deems it appropriate will hire (note: altho late filings she still delivers without having to file for a second filing late extension!). Because the additional $'s expended on developing the business has multifold return opportunities and one time cost whereas the costs of a CFO/IR etc are ONGOING overhead costs. AND moreso for front end loaded capital intensive biotechs with NWBO being MALIGNED by influence peddling AF.
Followup note on Susquehanna Intl Holdings from Wikipedia:
To wit: Susquehanna Intl Holdings is the 8th largest instl holder of NWBO AND has ~$48 Bln well diversified portfolio!.
My list of "Club of Ignores" is growing as logic,substance and depth of posts are lacking.